Home › Compare › TCAPF vs ABBV
TCAPF yields 6.02% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, TCAPF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCAPF + ABBV for your $10,000?
TP ICAP Group PLC provides intermediary services, contextual insights and intelligence, trade execution, pre-trade and settlement services, and data-led solutions in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in Global Broking, Energy & Commodities, Agency Execution, and Parameta Solutions divisions. The Global Broking division operates in rates, foreign exchange and money markets, emerging markets, equities, and credit products; and offers broking, facilitating price discovery, liquidity, execution, and risk management services to participants in the wholesale financial markets. The Energy & Commodities division operates in various commodities markets, including oil, gas, power, renewables, ferrous metals, base metals, precious metals, soft commodities, and coal. This division also assists in canvassing the market for expressions of interest, intelligence gathering, negotiations, and post-transaction processing; and provides insights on the impact of unpredictable factors, such as weather conditions, geopolitics, and exchange rate movements. The Agency Execution division operates Liquidnet, a cash equities dark/block electronic trading network; and Coex Partners, a trade advisory and agency execution service that covers listed derivatives, foreign exchange, government bonds, cleared interest rate swaps, and cash equities. This division serves hedge funds, asset managers, and asset owners. The Parameta Solutions division provides unbiased data products that facilitate trading, enhance transparency, reduce risk, and improve operational efficiency; and post trade solutions. This division also offers real-time price information for the OTC financial and commodity markets delivering independent data for various asset classes, including rates, foreign exchange and money markets, volatility, oil, energy, inflation, credit, and equities. TP ICAP Group PLC is based in St Helier, Jersey.
Full TCAPF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.